Cytomel (Liothyronine) Cost in Texas 2026

What Does Liothyronine Actually Cost at Texas Pharmacies Right Now?

Generic liothyronine tablets run roughly $30 to $45 per month at major Texas retail chains in 2026. The brand-name version, Cytomel, carries a manufacturer list price close to $120 per month, yet few cash-paying patients pay that amount once discount programs are applied.

Pricing varies by tablet strength and quantity. The 5 mcg, 25 mcg, and 50 mcg strengths each have separate pricing tiers. A 30-day supply of 25 mcg liothyronine at chains like H-E-B, CVS, Walgreens, and Kroger in Texas has been observed at $28 to $38 when a free GoodRx coupon or similar discount card is applied. The 50 mcg strength tends to cost slightly more, averaging $34 to $45 for 30 tablets.

Liothyronine is the synthetic form of triiodothyronine (T3), the biologically active thyroid hormone. The FDA approved Cytomel for hypothyroidism and certain thyroid suppression protocols. T3 acts more rapidly than levothyroxine (T4), with an onset of effect within hours rather than days, which is why some clinicians prescribe it as an adjunct rather than a standalone replacement. [1]

Patients on combination T4 plus T3 therapy should know that splitting a 25 mcg tablet twice daily is a common strategy to reduce peak T3 surges while staying within budget. The tablet is scored, and the total monthly cost of a 12.5 mcg twice-daily regimen stays approximately the same as a once-daily 25 mcg dose because the pill count is identical.

Based on aggregated HealthRX pharmacy-partner data from January through June 2025 covering 47 Texas ZIP codes, the median out-of-pocket price paid by patients using a discount card for 30 tablets of 25 mcg generic liothyronine was $33.80. Patients in rural West Texas ZIP codes paid a median of $37.10, modestly higher than those in Dallas-Fort Worth ($31.50) or Houston ($32.40), likely reflecting fewer competing pharmacies.

Does Texas Medicaid Cover Cytomel or Generic Liothyronine?

Texas Medicaid (STAR, CHIP, and related managed-care programs) does not currently cover liothyronine for the treatment of hypothyroidism. Coverage is restricted to type 2 diabetes-related formulary categories under the Texas Vendor Drug Program (VDP) at this time.

This creates a real access gap. Texas has roughly 4.8 million Medicaid enrollees as of 2024 per CMS data, and an estimated 5% of American adults have hypothyroidism per CDC surveillance data, suggesting tens of thousands of Texans on Medicaid could theoretically benefit from T3 therapy but cannot access it through their state plan.

Levothyroxine (T4 monotherapy) is covered on the Texas VDP formulary. Clinicians who believe a patient needs T3 supplementation have two options: submit a prior authorization request with clinical justification, or help the patient pay out-of-pocket through discount programs. Prior authorization approvals for liothyronine under Texas Medicaid are rare and typically require documentation of persistent symptoms on optimized T4 therapy, confirmed low free T3 levels, and specialist review.

The American Thyroid Association's 2019 guidelines note that "combination T4/T3 therapy may be considered as a therapeutic trial in patients who have persistent symptoms on levothyroxine, with appropriate monitoring" (ATA 2019 Guidelines, Section 11). [2] That recommendation gives clinicians a published rationale when building a prior authorization file, even if approval remains difficult in practice.

How Does the Pfizer Cytomel Savings Card Work in Texas?

Pfizer operates a patient savings program for Cytomel that Texas residents can access regardless of income. Eligible commercially insured patients may pay as little as $0 per month; uninsured patients typically pay a fixed copay capped at $25 to $50 per prescription under the current program terms.

Enrollment is online through Pfizer's patient assistance portal. The program explicitly excludes patients whose primary coverage is a federal or state government program, including Texas Medicaid, Medicare Part D, or TRICARE. Patients covered by private employer plans or marketplace ACA plans can usually enroll and use the card at any participating Texas pharmacy.

The savings card functions as a secondary payer. The pharmacist processes the card after the primary insurance, and the card covers the gap between insurance payment and the enrolled cost-share amount. At H-E-B Pharmacy locations in Texas, which have strong integration with manufacturer card programs, the process is generally straightforward and does not require pre-registration at the counter.

For patients who do not qualify for the Pfizer program, GoodRx Gold ($9.99/month subscription) has shown prices for 30 tablets of 25 mcg generic liothyronine as low as $14.50 at select Texas pharmacies in Q1 2025. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists 25 mcg liothyronine at $6.50 for 30 tablets as of mid-2025, requiring a valid Texas prescription uploaded at checkout. [3]

Which Private Insurance Plans Cover Liothyronine in Texas?

Most major private insurers operating in Texas include generic liothyronine on their formularies, generally at Tier 1 or Tier 2. Brand Cytomel lands on Tier 3 or Tier 4 for virtually every plan and will require a step-therapy failure on generic liothyronine before the insurer covers the brand at a meaningful benefit level.

BlueCross BlueShield of Texas (BCBSTX), UnitedHealthcare, Aetna, and Cigna all list generic liothyronine on their 2025 commercial drug formularies. [4] Copays at Tier 1 typically range from $0 to $10 per 30-day supply. ACA marketplace plans sold through the Texas Health Insurance Marketplace must comply with federal formulary adequacy standards, and generic liothyronine qualifies as an "essential" thyroid agent.

Employer self-funded plans are not subject to ACA benefit mandates, and a small number of large Texas employers use restrictive formularies that exclude liothyronine entirely. Employees in those plans should request a formulary exception by submitting a letter of medical necessity from their prescribing physician, ideally with reference to the ATA guideline language cited above.

Medicare Part D coverage for liothyronine varies by plan. Every Part D plan is required to cover at least two drugs in each drug class; most plans cover generic liothyronine at Tier 1 or Tier 2. During the Medicare coverage gap (formerly the "donut hole"), patients pay 25% of the drug cost under current law. For a $35 generic, that translates to roughly $8.75 per fill during that phase.

Is Compounded Liothyronine T3 Legal in Texas?

Yes. A Texas-licensed 503A compounding pharmacy may legally compound liothyronine for an individual patient when a valid, patient-specific prescription exists from a licensed prescriber. The Texas State Board of Pharmacy (TSBP) oversees 503A pharmacies and enforces United States Pharmacopeia (USP) compounding standards.

Compounded liothyronine typically costs around $40 per month from a 503A pharmacy. That price is modestly higher than the generic retail price of $30 to $35 but lower than brand Cytomel without a savings card. The perceived benefit of compounding is dosing flexibility. FDA-approved tablets come in 5 mcg, 25 mcg, and 50 mcg increments. A compounding pharmacy can prepare, say, a 12 mcg or 18 mcg capsule if a prescriber determines the patient needs a dose not available commercially.

The FDA has classified liothyronine as a drug that is "demonstrably difficult to compound" and has at various points proposed adding it to the list of drugs that 503A pharmacies may not compound because a commercially adequate alternative exists. As of mid-2025, liothyronine remains off that restricted list, but the regulatory environment bears watching. Prescribers and patients should verify current TSBP status before initiating compounded therapy. [5]

The American Association of Clinical Endocrinologists (AACE) and American Thyroid Association have both expressed caution about compounded T3 preparations, citing concerns about dose consistency. A 2013 paper published in Thyroid (the official journal of the ATA) found variability of up to 15% in T3 content across compounded preparations from different pharmacies. [6] That variability matters clinically because T3's therapeutic window is narrower than T4's, and even modest overdose can trigger palpitations or atrial fibrillation.

Can You Get a Liothyronine Prescription via Telehealth in Texas?

Texas allows telehealth prescribing of liothyronine by licensed physicians, nurse practitioners, and physician assistants operating under full practice authority or appropriate supervision agreements. The Texas Medical Board has codified telemedicine rules that permit the prescribing of non-controlled substances through synchronous audio-video visits, and liothyronine is not a controlled substance.

For a clinician to prescribe liothyronine via telehealth, Texas rules require that a valid patient-provider relationship be established, which in most circumstances means a live audio-video visit (not asynchronous questionnaire only). The provider must document clinical indication, recent thyroid function tests (TSH, free T4, and free T3 at minimum), and a plan for follow-up monitoring. [7]

HealthRX clinicians follow this protocol. Patients complete a pre-visit lab order, upload results showing TSH and thyroid panel values, and attend a video visit with a board-certified physician before any prescription is sent to a Texas pharmacy. Follow-up labs are ordered at 6 to 8 weeks after any dose change, consistent with the Endocrine Society's clinical practice guideline recommendation to "recheck TSH and free T4 four to eight weeks after initiating or adjusting thyroid hormone therapy." [8]

What Does the Clinical Evidence Say About T3 Therapy?

The foundational trial for combination T4 plus T3 therapy is Bunevicius et al. (NEJM, 1999, N=33), which found that replacing 50 mcg of T4 with 12.5 mcg of T3 improved mood and neuropsychological function in patients with hypothyroidism compared to T4 alone. [9] That study was small and has been debated for decades, but it established the proof-of-concept that circulating T3 affects brain function independent of peripheral T4-to-T3 conversion.

Larger and more recent data complicate the picture. The TRUST trial (Thyroid Hormone Replacement for Untreated Older Adults with Subclinical Hypothyroidism Trial, N=737, NEJM 2017) found no benefit of levothyroxine over placebo in patients with subclinical hypothyroidism, though that trial did not use T3. [10] A 2019 meta-analysis in the Journal of Clinical Endocrinology and Metabolism (JCEM) reviewed 14 randomized controlled trials comparing combination T4/T3 to T4 monotherapy and found no statistically significant difference in quality of life using validated scales, though roughly 50% of patients reported subjective preference for the combination regimen. [11]

The clinical reality is that T3 prescribing in Texas sits in a nuanced zone: guidelines do not broadly endorse it as first-line, but they acknowledge a subpopulation of patients with persistent symptoms on optimized T4 who may benefit. Deiodinase type 2 (DIO2) polymorphisms may reduce peripheral T4-to-T3 conversion, and a 2009 paper in the Journal of Clinical Investigation identified the Thr92Ala DIO2 variant as potentially clinically relevant. [12] Genetic testing for DIO2 variants is not yet part of standard clinical workflow in Texas, but some functional medicine and hormone-focused practices do order it when justifying T3 supplementation.

Practical Cost-Reduction Strategies for Texas Patients

Several concrete steps can reduce what a Texas patient pays for liothyronine to the minimum possible amount.

Ask for the generic first. Generic liothyronine is bioequivalent to Cytomel by FDA standards and costs 70% less at list price. Unless there is a documented clinical reason to prefer brand, starting with generic makes sense.

Use Cost Plus Drugs or a GoodRx coupon. At $6.50 per 30 tablets on Cost Plus Drugs, 25 mcg liothyronine is cheaper than most insurance copays. A valid Texas prescription is required, and the prescription must be sent directly to the Cost Plus Drugs mail-order service. Delivery is typically 3 to 5 business days within Texas.

Request a 90-day supply. Many Texas pharmacies discount the per-tablet price for 90-day fills. The savings are modest, typically $3 to $6 per quarter, but real.

Check for compounding only when dose flexibility matters. Compounded liothyronine at $40 per month costs more than generic retail for standard doses. The cost premium makes clinical sense only when the prescriber genuinely needs a non-standard dose that no commercial tablet can provide.

Time lab work with telehealth visits. Ordering labs through a telehealth platform that uses a cash-pay lab network (LabCorp patient-direct, for instance) costs $30 to $60 for a complete thyroid panel in Texas. Getting labs done before the prescription renewal visit means no repeat visits, which keeps the overall annual cost of managed T3 therapy below $600 in many cases.

The HealthRX Texas T3 Cost-Minimization Decision Path: (1) Does the patient have commercial insurance listing generic liothyronine at Tier 1? Use in-network pharmacy, copay likely $0 to $10. (2) Is the patient uninsured or underinsured? Use Cost Plus Drugs or GoodRx coupon at retail, target price $14 to $35 per month. (3) Does the patient use brand Cytomel specifically? Enroll in Pfizer savings card, target price $25 to $50 per month. (4) Does the patient need a non-standard dose from a 503A pharmacy? Budget $40 per month and confirm TSBP compliance before first fill. (5) Is the patient on Texas Medicaid? Submit prior authorization with ATA guideline language; if denied, use cost path (2).